Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BioAlliance plans phase II Clonidine Lauriad study expansion

April 18, 2012

New Exp1 inhibitors show promise in a number of in vitro and in vivo cancer studies

April 18, 2012

Daiichi Sankyo launches Ranmark in Japan

April 17, 2012

Merck & Co. gains worldwide rights to anticancer conjugate

April 17, 2012

Regeneron Pharmaceuticals generates new anticancer antibody

April 17, 2012

Two new promising oncology programs presented

April 17, 2012

Multitargeted antimitotic drug achieves tumor regression in vivo

April 17, 2012

Preclinical data support clinical testing of AVEO antibody

April 17, 2012

Exelixis discovers new PI3Kdelta inhibitors

April 17, 2012

Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics

April 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...